Analyst Ratings for Lexicon Pharmaceuticals (LXRX)
LXRX Rating Summary
LXRX Price Target Summary
- Highest: $6.00 (H.C. Wainwright)
- Lowest: $0.85 (Jefferies)
- Average: $2.92
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$2.92 (+70.6%)
* Over Last 12-Mos
Rating Score: 2.3 / 10
Percentile Rank: 18%
Rating Score: 2.3 / 10
Percentile Rank: 18%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2025 | Leerink Partners | Roanna Ruiz | Downgrade | Market Perform (Outperform) |
1.00 (N/A) |
0.29 (1.71) |
489.66% | Details |
| 6/17/2024 | H.C. Wainwright » Updated 3/5/2026 |
Joseph Pantginis | New Coverage | Buy (N/A) |
6.00 (4.00) |
1.82 (1.71) |
-6.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
